New to GLP-1s? Start with whether it's right for you ->
GLP-1 telehealth provider you can trust: the short answer
The GLP-1 telehealth provider you can trust most right now, by our scorecard, is Sesame Care - the highest composite (34.5/50, Tier B verging on A) of the cohort we have audited on a 10-axis doctor-ethical framework. Gala GLP-1 is the listed Tier B alternative (composite pending final verification). We dropped Strut Health entirely after the FDA issued it a warning letter (Reference 721448, February 2026) - a categorical disqualifier no matter the score. TMates is Under Review (composite ~25/50, below our 30-point linking floor). The point of publishing the scorecard is that you can audit which GLP-1 telehealth provider you can trust against the same axes a physician would use, not take our word for it.
The scorecard
Each axis is scored 1 to 5 the way a physician would evaluate where to send a patient. Patient-safety screening and product-quality verification carry 1.5× weight because they are the load-bearing safety signals. Axes we have not yet verified say so - we never invent a number.
| Axis | Weight | Sesame Care | Gala GLP-1 | TMates GLP-1 | Strut Health |
|---|---|---|---|---|---|
| Patient-safety screening | 1.5× | Pending verification | Pending verification | Pending verification | Pending verification |
| Product-quality verification | 1.5× | Pending verification | 2 / 5 | Pending verification | 2 / 5 |
| Informed consent and transparency | 1× | 4 / 5 | Pending verification | Pending verification | Pending verification |
| Prescriber model | 1× | 5 / 5 | Pending verification | Pending verification | Pending verification |
| Continuity of care | 1× | Pending verification | Pending verification | Pending verification | Pending verification |
| Conflict of interest disclosure | 1× | 4 / 5 | Pending verification | Pending verification | Pending verification |
| Pricing transparency and ethics | 1× | 5 / 5 | 3 / 5 | Pending verification | 5 / 5 |
| State coverage | 1× | Pending verification | Pending verification | Pending verification | 4 / 5 |
| Independent reputation | 1× | Pending verification | Pending verification | Pending verification | Pending verification |
| Specialization vs shotgun | 1× | 3 / 5 | 4 / 5 | 5 / 5 | 4 / 5 |
| Weighted composite | / 50 | 34.5 / 50 Tier B (provisional) | Pending Tier B (provisional) | 25 / 50 Under review | Pending Skip Tier - disqualified |
Live from our 10-axis doctor-ethical framework. Source data: /data/partner-scorecard.json. “Pending verification” means we hold the affiliate relationship but have not finished that axis - default to a fully scored partner until it publishes.
The audit log (proof the framework is real)
The scorecard moves both directions. We dropped our own former #1 pick on an FDA letter and publicly corrected an over-extension within 24 hours. That is the difference between a framework and a commission funnel.
2026-05-30 · Dropped · Strut Health
FDA Warning Letter 721448 (2026-02-20) cited false/misleading marketing on compounded semaglutide and tirzepatide labels. Categorical disqualifier - removed from all live placements regardless of composite score. Verified directly against the FDA warning-letter database.
2026-05-31 · Corrected · TMates
A third-party source alleged TMates marketed compounded products as 'FDA-approved.' Direct Playwright capture of tmates.com refuted it - the site actually states compounded medications 'are not evaluated by the FDA.' We removed the false disqualifier publicly. TMates still stays Under Review on a below-threshold composite and unnamed pharmacy partner. The correction is the framework working in both directions.
2026-05-30 · Promoted · Sesame Care
Promoted to primary GLP-1 partner after Strut's removal - highest audited composite, real video consult, transparent pricing, brand-name + insurance pathway surfaced honestly.
Full reasoning and every prior cycle is published at how we evaluate partners.
Where to get it
Honest take on where to source this peptide. Open the free account first; that's how we get credited even if you skip the code at checkout.
Transparent-pricing telehealth marketplace ยท Katalys
Sesame Care
Fits: You want a real video consult with a US-licensed provider who surfaces the brand-name + insurance pathway honestly alongside cash-pay compounded - not an async rubber-stamp. Composite 34.5/50, the highest of the audited cohort (Tier B verging on A).
Watch: Marketplace model: the experience varies by which provider you book, and 5 of 10 doctor-ethical axes are still pending our sign-up walkthrough. We score what we can verify and flag what we cannot. Read provider reviews before booking.
Step 1 Open a free account at Sesame Care ->Affiliate relationships are disclosed per FTC rules. Editorial take is independent of any commercial relationship; we only recommend what we'd actually use.
Questions readers actually ask
What is the most trusted GLP-1 telehealth provider right now?
By our 10-axis doctor-ethical scorecard, Sesame Care is the current top pick (34.5/50, Tier B verging on A) because it offers a real video consult with a US-licensed provider, transparent pre-booking pricing, and surfaces the brand-name + insurance pathway honestly instead of defaulting everyone to compounded. Gala GLP-1 (Tier B, composite pending final verification) is the listed alternative. Trust is per-axis, not a single star rating - the scorecard shows exactly where each provider is strong and where it is still pending verification.
Why did Protocol One drop Strut Health?
The FDA issued Strut Health a warning letter (Reference 721448, February 2026) citing false or misleading marketing on compounded semaglutide and tirzepatide product labels. A documented FDA warning letter for a partner pharmacy in the last 36 months is a categorical disqualifier in our framework - automatic Skip Tier regardless of how the rest of the scorecard looks. Strut was our previous top pick; we removed it from all live placements on 2026-05-30 and verified the letter directly against the FDA database.
How do I know your recommendation is not just the highest-commission partner?
Because the methodology is public and the scorecard contradicts us in plain sight if our picks do not match. We link the framework winner, not the commission winner, and we log every audit action - including dropping our own former #1 pick (Strut) and publicly correcting an over-extension on TMates within 24 hours. You can read every score, every reason, and every disqualifying line at /how-we-evaluate-partners.
What makes one GLP-1 telehealth provider more trustworthy than another?
We score ten axes the way a physician would weigh where to send a patient: patient-safety screening and product-quality verification (both 1.5x weight), informed-consent transparency, prescriber model, continuity of care, conflict-of-interest disclosure, pricing transparency, state coverage, independent reputation, and specialization. A GLP-1 telehealth provider you can trust names its 503A pharmacy, runs a real consult rather than a rubber-stamp, surfaces the brand-name and insurance path honestly, and prices transparently before signup. The scorecard shows exactly where each provider lands on each of those.
Is Gala GLP-1 a good alternative to Sesame Care?
Gala GLP-1 is our listed Tier B alternative (composite score pending final verification). It is the right pick if you want one flat all-in monthly price ($179/mo starter) that bundles medication, video provider visits, and support, plus a 2-minute qualification quiz before you commit. The trade-offs we disclose: the compounding pharmacy partner is not publicly named, and third-party reports flag BBB and billing complaints. For most readers Sesame Care is the primary because the doctor-first consult surfaces insurance options first, but Gala is a legitimate alternative with its trade-offs on the table.
Where to go next
- The full GLP-1 telehealth matrix - all the audited partners side by side
- How we evaluate partners - the 10-axis framework and the public audit log
- Should you get on a GLP-1? - the decision before the provider
- Subscribe to the dispatch
Subscribe to the dispatch
None of this replaces a doctor. Compounded GLP-1s are dispensed under the FDA 503A shortage framework, not FDA-approved. Pricing changes. Talk to a real prescriber before you start, switch, or stop anything.